GenSight Biologics adds CEO Laurence Rodriguez to its Board of Directors

– FRANCE, Paris – GenSight Biologics (EPA: SIGHT), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders, today announced the co-optation of CEO Laurence Rodriguez to its Board of Directors, replacing Bernard Gilly who resigned from the Board.…